Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase 'Multiple immune and tissue cell types via paracrine factors and cell-surface molecules' does not refer to a single molecular target but rather describes a complex physiological process of intercellular communication. This process is central to the function of the immune system and tissue homeostasis, where cells like mesenchymal stem cells (MSCs) or leukocytes influence their environment through secreted proteins (paracrine factors) and direct physical interactions (cell-surface molecules) [1][2]. In a therapeutic context, this often refers to the mechanism of action for cell-based therapies or broad-acting immunomodulators that aim to reprogram the local or systemic environment rather than inhibit a single enzyme or receptor [3]. Because it encompasses a vast array of distinct proteins and pathways—including interleukins, growth factors, and integrins—it lacks the specificity required for a canonical therapeutic target. Consequently, this entry is classified as a descriptive mechanism of action or a cellular interaction system rather than a discrete drug target [4]. Sources: [1] Galipeau, J., & Sensébé, L. (2018). Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell. [2] Pittenger, M. F., et al. (2019). Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regenerative Medicine. [3] Kyurkchiev, D., et al. (2014). Secretion of immunomodulatory factors by mesenchymal stem cells. World Journal of Stem Cells. [4] Alberts, B., et al. (2014). Molecular Biology of the Cell. Garland Science.
Modulation of the immune system and tissue repair through the coordinated secretion of soluble cytokines, chemokines, and growth factors (paracrine signaling) alongside direct physical interactions between membrane-bound ligands and receptors (cell-surface molecules).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple immune and tissue cell types via paracrine factors and cell-surface molecules.